All Title Author
Keywords Abstract


Estimation of Clinical, Immunological and Virological Failure of First Line Antiretroviral Treatment in Kinshasa, Democratic Republic of Congo

DOI: 10.4236/oalib.1104560, PP. 1-8

Subject Areas: HIV

Keywords: Treatment Failure, HIV, Kinshasa

Full-Text   Cite this paper   Add to My Lib

Abstract

Background: The prevalence of Human Immunodeficiency Virus (HIV) infection was 1.2% in the Democratic Republic of Congo, according to the Demographic Health Study report in 2014. In 2012, the severe failure rate to first-line ART in Kinshasa was estimated at more than 16%. Objective: The objective of this study is to determine the rate of clinical, immunological and virological failure in first-line treatment in Kinshasa. Methodology: At the 6th month of Antiretroviral Treatment (ART), 138 patients from a follow-up cohort of 8 centers in Kinshasa were received for paraclinical evaluations and analyses. The clinical and paraclinical parameters were recorded on the individual patient sheets as well as the survey forms. Clinical parameters, viral load and CD4 were evaluated at the 6th month of ART. Results: One hundred and thirty-eight (138) patients had returned for follow-up treatment, 81 women and 57 men. The average age of patients is 37 ± 12 years. The dominant age groups are those of 26 to 35 years and 36 to 45 years with 39 patients (28.3%) each, followed by those of 18 to 25 years (21.7%). One hundred and twenty-five (125) patients (90.5%) were in clinical stage 3 and 13 (9.5%) in clinical stage 4 according to the WHO classification. CD4 levels ranged from 98 to 1050 cells/mm3 and a median value of 560 cells/mm3. The median value of the patients’ VLs was 0.90 log10 copies of RNA/ml with respective minimum and maximum values of 0 and 4.82 log10 copies of RNA/ml. The virological failure rate was 24.6%. Conclusions: The rate of virological failure of first-line antiretroviral treatment of patients under treatment in Kinshasa is 24.6% for the year 2015.

Cite this paper

Kamangu, E. N. (2018). Estimation of Clinical, Immunological and Virological Failure of First Line Antiretroviral Treatment in Kinshasa, Democratic Republic of Congo. Open Access Library Journal, 5, e4560. doi: http://dx.doi.org/10.4236/oalib.1104560.

References

[1]  ONUSIDA. (2015) Rapport Mondial: Rapport ONUSIDA sur l’épidémie mondiale du SIDA en 2015.
[2]  (2014) Ministère du Plan et Suivi de la Mise en oeuvre de la Révolution de la Modernité et Ministère de la Santé Publique, République Démocratique du Congo. Enquête Démographique et de Santé 2013-2014: Rapport Annuel Préliminaire sur la Prévalence du VIH.
[3]  (2013) Programme National de la Lutte contre le Sida et les IST (PNLS), Ministère de la Santé Publique, République Démocratique du Congo. Guide National de Traitement de l’infection à VIH par les antirétroviraux chez l’adolescent et l’adulte.
[4]  Kamangu, N.E., Kalala, N.H. and Mesia, K.G. (2012) Profile of Antiretroviral Treatment Centers in Kinshasa, Democratic Republic of Congo. Proceedings of the 1st Conference of the African Society of Laboratory Medicine, Poster 388.
[5]  Kamangu, N.E., Kawila, M.E., Mukumbi, H. and Mvumbi, L.G. (2012) Estimated Rates of Treatment Failure in First-Line Antiretroviral Treatment in Kinshasa: Case of ACS AMO-CONGO. International Journal of Collaborative Research on Internal Medicine and Public Health, 4, 885-891.
[6]  Yéni, P. (2010) Prise en charge médicale des personnes infectées par le VIH. Recommandations du groupe d’Experts. Paris, France. Médecine Sciences, Flammarion.
[7]  Delfraissy, J.F. (2006) Prise en charge thérapeutique des personnes infectées par le VIH. Rapport 2004. Médecine-Sciences, Flammarion, Paris, France.
[8]  Morlat, P. (2013) Prise en Charge Médicale des Personnes Vivant avec le VIH: Recommandations du Groupe d’experts. Sous l’égide du CNS et de l’ANRS, Rapports.
[9]  Kamangu, N.E., Chatte, A., Boreux, R., Kalala, L.R., Mvumbi, L.G., De Mol, P., Vaira, D. and Hayette, M.P. (2014) Implementation of an In-House Quantitative Real-Time PCR for Determination of HIV Viral Load in Kinshasa. Open Access Library Journal, 1, e855.
[10]  Kamangu, N., Chatte, A., Boreux, R., Kalala, L.R., Mvumbi, L.G., Vaira, D. and Hayette, M.P. (2014) Mise en place d’une PCR Quantitative Temps Réel pour la détermination de la Charge Virale VIH à Kinshasa. Journal des Recherches Biomédicales, 1, 7-12.
[11]  Kamangu, N.E., Chatte, A., Boreux, R., Susin, F., Kalala, L.R., Mvumbi, L.G., De Mol, P., Hayette, M.P. and Vaira, D. (2015) Comparison of an In-House Quantitative Real Time PCR and COBAS AmpliPrep/TaqMan Roche for Determination of Viral Load for HIV Type 1 Non-B. Open Access Library Journal, 2, e1402.
[12]  Kamangu, N.E., Chatte, A., Susin, F., Boreux, R., Kalala, L.R., Mvumbi, L.G., De Mol, P., Vaira, D. and Hayette, M.P. (2015) Genetic Diversity and Antiretroviral Drug Resistance among Drug-Naive HIV Type 1 Infected Patients attending Clinics in Kinshasa, Democratic Republic of Congo. Journal of HIV and AIDS, 1, 1.
[13]  Kamangu, N.E., Bulanda, I.B., Bongenia, I.B., Botomwito, T.H., Mvumbi, L.G., Hayette, M.P. and Kalala, L.R. (2015) Virological Profile of Patients Infected with HIV Starting Antiretroviral Treatment in Kinshasa. Open Access Library Journal, 2, e1564.
[14]  Kamangu, N.E., Kawila, M.E., Mukumbi, H. and Mvumbi, L.G. (2012) Estimated Rates of Treatment Failure in First-Line Antiretroviral Treatment in Kinshasa: Case of the ACS AMO-Congo. International Journal of Collaborative Research on Internal Medicine and Public Health, 4, 885-891.
[15]  Kamangu, N.E., Situakibanza, N.H., Mvumbi, L.G., Kakudji, I.L., Tshienda, T.D. and Mesia, K.G. (2012) Infections Opportunistes chez les Personnes Vivant avec le VIH suivi à l’Hopital Militaire de Référence de Kinshasa (Camp Kokolo). Revue Congolaise des Sciences, 1, 66-76.
[16]  Bongenya, B., Ilombo, L., Botomwito, H., Bulanda, B., Kamangu, E., Lusakibanza, M. and Mesia, G. (2014) Fréquence du Suivi des Paramètres Biologiques des Patients sous Antirétroviraux à Kinshasa: Cas de l’H?pital Provincial Général de Référence. Journal des Recherches Biomédicales, 1, 1-6.
[17]  Muwonga, J., Edidi, S., Butel, C., Vidal, N., Monleau, M., Okenge, A., Mandjo, J.L., Mukumbi, H., Muyembe, J.J., Mbayo, F., Kayembe, D., Delaporte, E., Boillot, F. and Peeters, M. (2011) Resistance to Antiretroviral Drugs in Treated and Drug-Naive Patients in the Democratic Republic of Congo. Journal of Acquired Immune Deficient Syndrome, 57, S27-S33.

Full-Text


comments powered by Disqus